1-20 of 40
Keywords: Levofloxacin
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Chemotherapy (2019) 64 (1): 8–16.
Published Online: 21 May 2019
... infections, which are mainly caused by Gram-negative pathogens. For years, levofloxacin and other FQs have been the first-line drugs for treating National Institutes of Health (NIH) category II chronic bacteria prostatitis (CBP). Eradication rates achieved by levofloxacin in the frame of randomized trials...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Chemotherapy (1993) 39 (1): 36–39.
Published Online: 11 September 2009
...S.C. Lafredo; B.D. Foleno; K.P. Fu Twelve strains of Streptococcus pneumoniae were serially exposed to increasing concentrations of levofloxacin, temafloxacin, ciprofloxacin and norfloxacin for five passages. Wild-type and passaged strains were tested for susceptibility to quinolones, macrolide...
Journal Articles
Chemotherapy (1993) 39 (2): 120–123.
Published Online: 11 September 2009
...B.D. Foleno; S.C. Lafredo; K.P. Fu The in vitro activity of levofloxacin against coagulase-negative staphylococci (CNS) was investigated. In vitro, on the basis of MIC 90 values, levofloxacin was as active as ciprofloxacin, inhibiting both methicillin-sensitive and -resistant staphylococci at 0.5...
Journal Articles
Journal Articles
Chemotherapy (2007) 54 (1): 50–53.
Published Online: 10 December 2007
... susceptibilities of clarithromycin, metronidazole, amoxicillin, tetracycline and telithromycin against levofloxacin-resistant H. pylori in Hong Kong. Methods: One hundred and ninety-one nonduplicate H. pylori isolates were collected during 2004 and 2005, and 25 isolates with levofloxacin zone sizes less than 30 mm...
Journal Articles
Journal Articles
Chemotherapy (2007) 53 (2): 85–103.
Published Online: 26 January 2007
... attention in Japan. Methods: The safety of levofloxacin (LVX) was investigated in Japan by post-marketing surveillance and reviewing spontaneous reports. Results: Post-marketing surveillance was performed in 16,117 patients between 1994 and 1996. The incidence of adverse reactions was 1.3% (203/16,117...
Journal Articles
Chemotherapy (2005) 51 (1): 44–50.
Published Online: 04 April 2005
...Agata Lanzafame; Giovanni Bonfiglio; Luca Santini; Roberto Mattina The objective of our study was to evaluate the in vitro activity of levofloxacin in comparison with other antibiotics (coamoxiclav, ceftriaxone, ceftazidime, meropenem, aztreonam, ciprofloxacin and netilmicin) against about 500 Gram...
Journal Articles
Chemotherapy (2004) 50 (Suppl. 1): 11–15.
Published Online: 18 August 2004
... was performed to assess the results of CAP treatment using a clinical pathway that incorporated admission guidelines, standard treatment orders with oral levofloxacin or cefuroxime axetil plus azithromycin, and an algorithm for oxygen therapy and discharge. The study involved seven centers enrolling 7,734...
Journal Articles
Chemotherapy (2004) 50 (Suppl. 1): 3–10.
Published Online: 18 August 2004
..., of which levofloxacin has been available for the longest time, currently remain active against the great majority of common bacterial respiratory pathogens, including atypicals. 18 8 2004 © 2004 S. Karger AG, Basel 2004 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved...
Journal Articles
Chemotherapy (2004) 50 (Suppl. 1): 16–21.
Published Online: 18 August 2004
...Wolfgang Graninger; Markus Zeitlinger New fluoroquinolones, as exemplified by levofloxacin, possess broad spectrum activity against many common pathogens, including the majority responsible for respiratory tract infections (RTIs), atypical pathogens and those resistant to other therapeutic regimens...
Journal Articles
Chemotherapy (2004) 50 (Suppl. 1): 22–28.
Published Online: 18 August 2004
...Thomas M. File Jr. Levofloxacin is widely regarded as one of the most important fluoroquinolones available today. It possesses excellent activity against a wide range of important pathogens, including those resistant to many other antimicrobials. While rates of resistance to other previously useful...
Journal Articles
Journal Articles
Journal Articles
Chemotherapy (2003) 48 (6): 275–279.
Published Online: 10 April 2003
.... Monoexponentially declining concentrations observed in human plasma after oral administration of 1,000 mg of ciprofloxacin (as two 500-mg doses at a 12-hour interval), 320 mg gemifloxacin, 500 mg levofloxacin or 400 mg moxifloxacin (each as a single dose) and were simulated in an in vitro dynamic model...